Editorial: More is simply more and not necessarily better

Journal of Urology

Volumn 156, Issue 1, 1996, Pages 61-62

  Badalament, R A ^a  

^a Crittenton Hospital Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTOSCOPY; CYTOMETRY; EDITORIAL; IMAGE ANALYSIS; PLOIDY; PRIORITY JOURNAL; RESIDENCY EDUCATION; TRANSITIONAL CELL CARCINOMA; UROLOGY; BLADDER TUMOR; HUMAN; NOTE; PATHOLOGY;

HUMANS; URINARY BLADDER NEOPLASMS;

EID: 0030186718     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65939-1     Document Type: Editorial

References (11)

1. Ponka J.L. Hernias of the Abdominal Wall 1980 W. B. Saunders Co. Philadelphia
2. Badalament R.A. Kimmel M. Gay H. Cibas E.S. Whitmore W.F. Jr. Herr H.W. Fair W.R. Melamed M.R. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma Cancer 59 1987 2078
3. Badalament R.A. Hermansen D.K. Kimmel M. Gay H. Herr H.W. Fair W.R. Whitmore W.F. Jr. Melamed M.R. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma Cancer 60 1987 1423
4. Wheeless L.L. Badalament R.A. de Vere White R.W. Fradet Y. Tribukait B. Consensus review of the clinical utility of DNA cytometry in bladder cancer Report of the DNA Cytometry Consensus Conference. Cytometry 14 1993 478
5. Tribukait, B.: Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J. Urol., 5: 108, 1087.
6. Badalament R.A. Drago J.R. Advances in the diagnosis and management of bladder cancer: flow cytometry, intravesical bacillus Calmette-Guerin, and systemic chemotherapy J. Surg. Oncol. 42 1989 33
7. Hermansen D.K. Badalament R.A. Bretton P.R. Kimmel M. Aswad C.M. Whitmore W.F. Jr. Melamed M.R. Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer J. Occup. Med. 32 1990 894
8. Badalament R.A. Fair W.R. Whitmore W.F. Jr. Melamed M.R. The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience Sem. Urol. 6 1988 22
9. Rinitala E. Juahiainen K. Alfthan O. Hansson E. Juusela H. Kanerva K. Korhonen H. Permi J. Sotarauta M. Vaalasti T. Vittanen J.M. Usenius R. Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guerin) in superficial bladder cancer Eur. Urol. 20 1991 19
10. Lamm D.L. Torti F.M. Bladder cancer, 1996 CA 46 1996 93
11. Wientjes M.G. Badalament R.A. Au J.L. Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer Cancer Chemother. Pharmacol. 32 1993 255